ZhuZhou QianJin Pharmaceutical Co Ltd
SSE:600479
Wall Street
Price Targets
Price Targets Summary
ZhuZhou QianJin Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for ZhuZhou QianJin Pharmaceutical Co Ltd is 15.22 CNY .
Revenue
Forecast
Revenue Estimate
ZhuZhou QianJin Pharmaceutical Co Ltd
For the last 8 years the compound annual growth rate for ZhuZhou QianJin Pharmaceutical Co Ltd's revenue is 8%. The projected CAGR for the next 4 years is -3%.
Operating Income
Forecast
Operating Income Estimate
ZhuZhou QianJin Pharmaceutical Co Ltd
For the last 8 years the compound annual growth rate for ZhuZhou QianJin Pharmaceutical Co Ltd's operating income is 16%. The projected CAGR for the next 7 years is -14%.
Net Income
Forecast
Net Income Estimate
ZhuZhou QianJin Pharmaceutical Co Ltd
For the last 8 years the compound annual growth rate for ZhuZhou QianJin Pharmaceutical Co Ltd's net income is 14%. The projected CAGR for the next 4 years is -3%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ZhuZhou QianJin Pharmaceutical Co Ltd's stock price target?
Price Target
15.22
CNY
According to Wall Street analysts, the average 1-year price target for ZhuZhou QianJin Pharmaceutical Co Ltd is 15.22 CNY .
What is ZhuZhou QianJin Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
-3%
For the last 8 years the compound annual growth rate for ZhuZhou QianJin Pharmaceutical Co Ltd's revenue is 8%. The projected CAGR for the next 4 years is -3%.
What is ZhuZhou QianJin Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
-14%
For the last 8 years the compound annual growth rate for ZhuZhou QianJin Pharmaceutical Co Ltd's operating income is 16%. The projected CAGR for the next 7 years is -14%.
What is ZhuZhou QianJin Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
-3%
For the last 8 years the compound annual growth rate for ZhuZhou QianJin Pharmaceutical Co Ltd's net income is 14%. The projected CAGR for the next 4 years is -3%.